SYMPATHOADRENAL AND CATECHOLAMINE FUNCTION IN HEALTH
健康中的交感肾上腺和儿茶酚胺功能
基本信息
- 批准号:6163057
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Menkes' syndrome Parkinson's disease catecholamines clinical research congestive heart failure disease /disorder classification dopamine epinephrine familial dysautonomia gastrointestinal system homeostasis hormone regulation /control mechanism human subject neurochemistry neuroendocrine system neuroregulation neurotransmitter biosynthesis norepinephrine perfusion peripheral nervous system disorders positron emission tomography postural hypotension prodrugs sympathetic nervous system syncope
项目摘要
Catecholamine systems, operating at the interface between the mind and the
body, exemplify three ways the brain regulates homeostasis -- via
neurotransmitters (norepinephrine, NE), hormones (epinephrine, EPI), and
autocrine/paracrine factors (dopamine, DA). We conducted investigations in
the areas of clinical neurocardiology, catecholamine neurochemistry, and
novel catecholaminergic systems. 6-[18F]fluorodopamine ([18F]-6F-DA)
positron-emission tomographic (PET) scanning led to a new
pathophysiological classification of primary chronic autonomic failure.
Patients with pure autonomic failure (PAF) or parkinsonism and autonomic
failure had cardiac sympathetic denervation, whereas patients with the
Shy-Drager syndrome had decreased or absent post-ganglionic sympathetic
neural outflows to intact nerve terminals. 13N-ammonia and [18F]-6F-DA PET
scanning detected perfusion or sympathoneural abnormalities in the
affected limbs of patients with sympathetic dystrophy (RSD). Patients
prone to neurocardiogenic syncope had decreased cardiac NE spillover, and
patients with hypertrophic cardiomyopathy (HCM) had intact sympathetic
innervation of the hypertrophic myocardium. Clinical neurochemical studies
linked specific catecholaminergic phenotypes with genotypic abnormalities
in Menkes' disease, familial dysautonomia (FD), and L-aromatic-amino-acid
decarboxylase (LAAAD) deficiency. Treatment with L-DOPA as a dopaminergic
pro-drug produced beneficial natriuretic responses in patients with
congestive heart failure. Plasma DA-sulfate levels were found to depend on
dietary factors and on production of endogenous DA in the gastrointestinal
tract.
儿茶酚胺系统,在大脑和大脑之间的界面上运行
身体,例证了大脑调节动态平衡的三种方式--通过
神经递质(去甲肾上腺素,NE)、激素(肾上腺素,EPI)和
自分泌/旁分泌因子(多巴胺、多巴胺)。我们在以下方面进行了调查
临床神经心脏病学、儿茶酚胺神经化学和
新型儿茶酚胺能系统。6-[18F]氟多胺([18F]-6F-DA)
正电子发射断层扫描(PET)导致了一种新的
原发性慢性自主神经衰竭的病理生理分类。
单纯自主神经衰竭(PAF)或帕金森病合并自主神经的患者
衰竭会导致心脏交感神经丧失,而患有心力衰竭的患者
Shy-Drager综合征节后交感神经减少或缺失
神经流出到完整的神经末梢。13N-氨和[18F]-6F-DA PET
扫描检测到脑血流灌注或交感神经异常。
交感神经营养不良(RSD)患者患肢。病人
易发生神经性心源性晕厥的患者心脏去甲肾上腺素外溢减少,且
肥厚型心肌病(HCM)患者的交感神经完整
肥大心肌的神经支配。临床神经化学研究
特异儿茶酚胺能表型与基因异常相关
家族性自主神经功能障碍与L芳香族氨基酸
脱羧酶(LAAAD)缺乏症。L多巴作为多巴胺能药的治疗
前体药物在慢性阻塞性肺疾病患者中产生有益的利钠反应
充血性心力衰竭研究发现,血浆DA-硫酸盐水平依赖于
饮食因素与胃肠道内源性多巴胺的产生
一条小路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
D S GOLDSTEIN其他文献
D S GOLDSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('D S GOLDSTEIN', 18)}}的其他基金
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
试点项目 - 自主神经罕见疾病临床研究联盟
- 批准号:
7901216 - 财政年份:2009
- 资助金额:
-- - 项目类别:
COLLABORATIVE STUDIES OF NEUROENDOCRINE PHARMACOLOGY AND PHYSIOLOGY
神经内分泌药理学和生理学的合作研究
- 批准号:
3966593 - 财政年份:
- 资助金额:
-- - 项目类别:
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
试点项目 - 自主神经罕见疾病临床研究联盟
- 批准号:
8380488 - 财政年份:
- 资助金额:
-- - 项目类别:
SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE
健康和疾病中的交感肾上腺和儿茶酚胺能功能
- 批准号:
5203972 - 财政年份:
- 资助金额:
-- - 项目类别:
SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE
健康和疾病中的交感肾上腺和儿茶酚胺能功能
- 批准号:
3846315 - 财政年份:
- 资助金额:
-- - 项目类别:
SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE
健康和疾病中的交感肾上腺和儿茶酚胺能功能
- 批准号:
3782423 - 财政年份:
- 资助金额:
-- - 项目类别:
PLASMA CATECHOLAMINES AND SYMPATHETIC ACTIVITY IN CLINICAL HYPERTENSION
临床高血压中的血浆儿茶酚胺和交感神经活动
- 批准号:
4694562 - 财政年份:
- 资助金额:
-- - 项目类别:
PLASMA CATECHOLAMINES AND SYMPATHETIC ACTIVITY IN CLINICAL HYPERTENSION
临床高血压中的血浆儿茶酚胺和交感神经活动
- 批准号:
3966596 - 财政年份:
- 资助金额:
-- - 项目类别:
SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE
健康和疾病中的交感肾上腺和儿茶酚胺能功能
- 批准号:
3760325 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
- 批准号:
2907463 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Studentship
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
- 批准号:
2898794 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Studentship
The Diagnostic and Prognostic Utility of Eye Tracking in Parkinson's Disease and Related Disorders
眼动追踪在帕金森病及相关疾病中的诊断和预后效用
- 批准号:
479285 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Neurophysiological mechanism underlying freezing of gait in Parkinson's disease: transcutaneous spinal cord stimulation for gait disturbance
帕金森病步态冻结的神经生理机制:经皮脊髓刺激治疗步态障碍
- 批准号:
23K10409 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inhibition of cell-to-cell propagation of alpha-synuclein aggregation by glial cells and its involvement in neuropathology in Parkinson's disease.
神经胶质细胞抑制α-突触核蛋白聚集的细胞间传播及其参与帕金森病的神经病理学。
- 批准号:
23K06928 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Propagation of a-synuclein in Parkinson's disease progress
α-突触核蛋白在帕金森病进展中的传播
- 批准号:
22KJ2095 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for JSPS Fellows
Drug-microbiome-host interactions in Parkinson's disease
帕金森病的药物-微生物组-宿主相互作用
- 批准号:
2881438 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Studentship
Ordering the disordered in Parkinson's disease to derive peptide inhibitors of alpha-synuclein toxicity
命令帕金森病患者衍生出α-突触核蛋白毒性的肽抑制剂
- 批准号:
2884235 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Studentship
MICA: How does the pedunculopone nucleus influence treatment responses in Parkinson's disease, and can it be targeted for new treatment strategies
MICA:脚核如何影响帕金森病的治疗反应,是否可以作为新治疗策略的目标
- 批准号:
MR/X005267/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Research Grant